Searching for Solutions

No summary available

No summary available

AAPP partnered with Pharmacy Times to record a Pharmacy Focus podcast focused on emerging trends in psychiatric pharmacotherapy as presented at AAPP 2026, held April 19-22 in WA.

The FDA granted de novo approval for a neuromodulation device to treat symptoms associated with post-traumatic stress disorder (PTSD). The wearable, non-invasive device -- dubbed Modius Spero -- uses electrical vestibular system stimulation to target specific brain areas. It is prescribed and overseen by a healthcare professional as part of a comprehensive PTSD care plan.

The Department of Veterans Affairs (VA) on Tuesday announced a new clinical trial of methylenedioxymethamphetamine-assisted therapy, more commonly known as MDMA, to evaluate the safety and efficacy when treating current and former military personnel for severe mental health disorders including posttraumatic stress disorder (PTSD) and alcohol use disorder.

The SSP-based model provided rapid access to buprenorphine prescriptions, but precipitated withdrawal was a common complication.

Public sentiment on Regulations.gov supports the United States Drug Enforcement Administration's proposal for cannabis rescheduling, though the majority views the proposed Schedule III classification as inadequate and supports further rescheduling or complete de-scheduling of cannabis.

This study offers novel data on opioid-related medication access for adolescents with illicit fentanyl exposure.

Formalizing FA assessment and diagnosis, and improving reimbursement mechanisms, may reduce potential health inequities between market-driven and publicly funded SUD treatment centers in FA treatment and referral resources.

This study's findings suggest that provision of in-jail MOUD could improve methadone uptake in the community.

Social anxiety and psychiatric concerns are salient barriers to attending a variety of MHG groups and to MHG involvement.

This randomized controlled trial provides the first evidence that a pharmacological intervention, buprenorphine, significantly sustains and enhances the antisuicidal effects of ketamine in MDD.

Whether you’re actively seeking to fill a position, job searching yourself, or simply keeping an eye on new opportunities, AAPP’s new Career Center helps psychiatric pharmacists explore jobs, upload a resume, save positions, and compare cost of living across cities. #PsychPharm #Jobs

This review aimed to update current knowledge on causality and risk relationships to inform global and national comparative risk assessments for alcohol.